Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Osteoporosis International
Published in: Osteoporosis International 12/2014

01-12-2014 | Original Article

Cost-effectiveness of training rural providers to identify and treat patients at risk for fragility fractures

Authors: S. D. Nelson, R. E. Nelson, G. W. Cannon, P. Lawrence, M. J. Battistone, M. Grotzke, Y. Rosenblum, J. LaFleur

Published in: Osteoporosis International | Issue 12/2014

Login to get access

Abstract

Summary

This is a cost-effectiveness analysis of training rural providers to identify and treat osteoporosis. Results showed a slight cost savings, increase in life years, increase in treatment rates, and decrease in fracture incidence. However, the results were sensitive to small differences in effectiveness, being cost-effective in 70 % of simulations during probabilistic sensitivity analysis.

Introduction

We evaluated the cost-effectiveness of training rural providers to identify and treat veterans at risk for fragility fractures relative to referring these patients to an urban medical center for specialist care. The model evaluated the impact of training on patient life years, quality-adjusted life years (QALYs), treatment rates, fracture incidence, and costs from the perspective of the Department of Veterans Affairs.

Methods

We constructed a Markov microsimulation model to compare costs and outcomes of a hypothetical cohort of veterans seen by rural providers. Parameter estimates were derived from previously published studies, and we conducted one-way and probabilistic sensitivity analyses on the parameter inputs.

Results

Base-case analysis showed that training resulted in no additional costs and an extra 0.083 life years (0.054 QALYs). Our model projected that as a result of training, more patients with osteoporosis would receive treatment (81.3 vs. 12.2 %), and all patients would have a lower incidence of fractures per 1,000 patient years (hip, 1.628 vs. 1.913; clinical vertebral, 0.566 vs. 1.037) when seen by a trained provider compared to an untrained provider. Results remained consistent in one-way sensitivity analysis and in probabilistic sensitivity analyses, training rural providers was cost-effective (less than $50,000/QALY) in 70 % of the simulations.

Conclusions

Training rural providers to identify and treat veterans at risk for fragility fractures has a potential to be cost-effective, but the results are sensitive to small differences in effectiveness. It appears that provider education alone is not enough to make a significant difference in fragility fracture rates among veterans.
Appendix
Available only for authorised users
Literature
1.
Gennari L, Bilezikian JP (2007) Osteoporosis in men. Endocrinol Metab Clin N Am 36:399–419CrossRef
2.
National Osteoporosis Foundation (2010) Clinician’s Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation
3.
Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301:513–521PubMedCrossRef
4.
Fransen M, Woodward M, Norton R, Robinson E, Butler M, Campbell AJ (2002) Excess mortality or institutionalization after hip fracture: men are at greater risk than women. J Am Geriatr Soc 50:685–690PubMedCrossRef
5.
Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 22:465–475PubMedCrossRef
6.
Kane T (2006) Who are the recruits? The demographic characteristics of U.S. Military Enlistment, 2003–2005. Center for Data Analysis Report #06-09. Heritage Foundation, Washington, DC
7.
Weeks WB, Wallace AE, Wang S, Lee A, Kazis LE (2006) Rural-urban disparities in health-related quality of life within disease categories of veterans. J Rural Health 22:204–211PubMedCrossRef
8.
Wallace AE, Lee R, Mackenzie TA, West AN, Wright S, Booth BM, Hawthorne K, Weeks WB (2010) A longitudinal analysis of rural and urban veterans’ health-related quality of life. J Rural Health 26:156–163PubMedCrossRef
9.
10.
Nelson RE, Hicken B, West A, Rupper R (2012) The effect of increased travel reimbursement rates on health care utilization in the VA. J Rural Health 28:192–201PubMedCrossRef
11.
Nelson RE, Battistone MJ, Ashworth WD, Barker AM, Grotzke M, Huhtala TA, Lafleur J, Tashjian RZ, Cannon GW (2013) Cost effectiveness of training rural providers to perform joint injections. Arthritis Care Res (Hoboken) 66(4):559--66. doi:10.​1002/​acr.​22179
12.
LaFleur J, Nelson R, Adler R, Nebeker J, Nelson S, Smith J, Malone D (2012) Cost-effectiveness analysis of different strategies for fragility fracture prevention in United States male veterans. ISPOR 17th Annual International Meeting. Value in Health, Washington, D.C., p A8
13.
Nelson S, Malone D, LaFleur J (2014) Calculating the baseline incidence in patients without risk factors: a strategy for economic evaluation. Manuscript submitted for publication
14.
Sawka AM, Papaioannou A, Adachi JD, Gafni A, Hanley DA, Thabane L (2005) Does alendronate reduce the risk of fracture in men? A meta-analysis incorporating prior knowledge of anti-fracture efficacy in women. BMC Musculoskelet Disord 6:39PubMedCentralPubMedCrossRef
15.
Bone HG, Hosking D, Devogelaer JP et al (2004) Ten years’ experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 350:1189–1199PubMedCrossRef
16.
Mellstrom DD, Sorensen OH, Goemaere S, Roux C, Johnson TD, Chines AA (2004) Seven years of treatment with risedronate in women with postmenopausal osteoporosis. Calcif Tissue Int 75:462–468PubMedCrossRef
17.
LaFleur J, Pickard S, Nebeker J (2008) Recognition and treatment of male osteoporosis is low in at least one VISN. HSR&D National Meeting, Baltimore
18.
Arias E (2011) United States Life Tables, 2007. Natl Vital Stat Rep. Division of Vital Statistics, Centers for Disease Control, Washington, D.C., p 61
19.
Ito K, Hollenberg JP, Charlson ME (2009) Using the osteoporosis self-assessment tool for referring older men for bone densitometry: a decision analysis. J Am Geriatr Soc 57:218–224PubMedCrossRef
20.
Melton LJ 3rd (2000) Excess mortality following vertebral fracture. J Am Geriatr Soc 48:338–339PubMed
21.
Browner WS, Pressman AR, Nevitt MC, Cummings SR (1996) Mortality following fractures in older women. The study of osteoporotic fractures. Arch Intern Med 156:1521–1525PubMedCrossRef
22.
Ettinger B, Black DM, Dawson-Hughes B, Pressman AR, Melton LJ 3rd (2010) Updated fracture incidence rates for the US version of FRAX. Osteoporos Int 21:25–33PubMedCentralPubMedCrossRef
23.
Schousboe JT, Taylor BC, Fink HA, Kane RL, Cummings SR, Orwoll ES, Melton LJ 3rd, Bauer DC, Ensrud KE (2007) Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. JAMA 298:629–637PubMedCrossRef
24.
Brunkhorst FM, Engel C, Ragaller M et al (2008) Practice and perception—a nationwide survey of therapy habits in sepsis. Crit Care Med 36:2719–2725PubMedCrossRef
25.
Stone PW, Pogorzelska-Maziarz M, Herzig CT, Weiner LM, Furuya EY, Dick A, Larson E (2014) State of infection prevention in US hospitals enrolled in the National Health and Safety Network. Am J Infect Control 42:94–99PubMedCrossRef
26.
Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR (1999) Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA 282:1458–1465PubMedCrossRef
Metadata
Title
Cost-effectiveness of training rural providers to identify and treat patients at risk for fragility fractures
Authors
S. D. Nelson
R. E. Nelson
G. W. Cannon
P. Lawrence
M. J. Battistone
M. Grotzke
Y. Rosenblum
J. LaFleur
Publication date
01-12-2014
Publisher
Springer London
Published in
Osteoporosis International / Issue 12/2014
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-014-2815-1

Other articles of this Issue 12/2014

Osteoporosis International 12/2014 Go to the issue

Original Article

Comparison of the effect of 18-month daily teriparatide administration on patients with rheumatoid arthritis and postmenopausal osteoporosis patients

Erratum

Erratum to: Prevalence of renal impairment among osteoporotic women in the USA, NHANES 2005–2008: is treatment with bisphosphonates an option?

Original Article

A Frailty Index predicts 10-year fracture risk in adults age 25 years and older: results from the Canadian Multicentre Osteoporosis Study (CaMos)

Review

Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption–formation cycles?

Original Article

Differences in persistency with teriparatide in patients with osteoporosis according to gender and health care provider

Original Article

Does diabetes modify the effect of FRAX risk factors for predicting major osteoporotic and hip fracture?